An experimental therapy designed by an Argentinian team will begin human trials next month, advancing on a path that could make it, in a few years, the world's first available treatment to block chronic pain for weeks without the risk of addiction associated with opioid painkillers and the adverse effects of other medications that lead to treatment abandonment.

Coverage in other media: elonce.com, palermonline.com.ar, pilardetodos.com.ar, noticiasbariloche.com.ar, enorsai.com.ar, noticiasradioreflejos.com.ar, programainfosalud.com, misionescuatro.com, lavoz901.com, colonbuenosaires.com.ar/ElFaro, revistachacra.com.ar, diarioresumen.com.ar, Agritotal.com, Noticiasdebariloche.com.ar, programainfosalud.com, Miradaprofesional.com